Chinese english Germany Japanese Korea

(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one

(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one Struktur
CAS-Nr.
Englisch Name:
(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one
Synonyma:
7-Nerolidyl indolactam V;(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one
CBNumber:
CB92169942
Summenformel:
C32H47N3O2
Molgewicht:
505.73448
MOL-Datei:
Mol file
Request For Quotation

(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one Eigenschaften

Sicherheit

(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one Chemische Eigenschaften,Einsatz,Produktion Methoden

(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
  • (2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one
  • 7-Nerolidyl indolactam V
Copyright 2019 © ChemicalBook. All rights reserved